All articles tagged with #oral pill
The FDA has approved Revolution Medicines' daily oral pill therapy to treat pancreatic cancer, marking a milestone in targeted, non-invasive cancer treatment based on recent clinical-trial results.
At the JPMorgan Healthcare Conference, executives from Lilly, Novo Nordisk, Pfizer and others said the obesity-drug market will broaden beyond injections to a menu of options—oral GLP-1 pills, combination regimens, and treatments aimed at preserving muscle—while prices fall, Medicare coverage rolls out, and direct-to-consumer channels grow, potentially pushing the market toward $100 billion annually by 2030 as new entrants and tailored therapies expand patient access and choices.